Logo image of 1MRKX.MI

MERCK & CO. INC. (1MRKX.MI) Stock Fundamental Analysis

Europe - BIT:1MRKX - US58933Y1055 - Common Stock

81.2 EUR
+0.1 (+0.12%)
Last: 11/17/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to 1MRKX. 1MRKX was compared to 54 industry peers in the Pharmaceuticals industry. 1MRKX scores excellent on profitability, but there are some minor concerns on its financial health. 1MRKX may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make 1MRKX a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year 1MRKX was profitable.
1MRKX had a positive operating cash flow in the past year.
In the past 5 years 1MRKX has always been profitable.
1MRKX had a positive operating cash flow in each of the past 5 years.
1MRKX.MI Yearly Net Income VS EBIT VS OCF VS FCF1MRKX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

With an excellent Return On Assets value of 14.69%, 1MRKX belongs to the best of the industry, outperforming 87.04% of the companies in the same industry.
1MRKX has a Return On Equity of 36.71%. This is amongst the best in the industry. 1MRKX outperforms 88.89% of its industry peers.
With a decent Return On Invested Capital value of 12.83%, 1MRKX is doing good in the industry, outperforming 62.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1MRKX is in line with the industry average of 14.51%.
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROIC 12.83%
ROA(3y)9.42%
ROA(5y)9.66%
ROE(3y)23.17%
ROE(5y)26.32%
ROIC(3y)13.67%
ROIC(5y)12.02%
1MRKX.MI Yearly ROA, ROE, ROIC1MRKX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

1MRKX has a Profit Margin of 29.63%. This is amongst the best in the industry. 1MRKX outperforms 90.74% of its industry peers.
1MRKX's Profit Margin has been stable in the last couple of years.
1MRKX has a Operating Margin of 38.08%. This is amongst the best in the industry. 1MRKX outperforms 88.89% of its industry peers.
1MRKX's Operating Margin has improved in the last couple of years.
1MRKX's Gross Margin of 78.72% is fine compared to the rest of the industry. 1MRKX outperforms 79.63% of its industry peers.
1MRKX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.08%
PM (TTM) 29.63%
GM 78.72%
OM growth 3Y5.75%
OM growth 5Y7.99%
PM growth 3Y-0.15%
PM growth 5Y1.18%
GM growth 3Y1.92%
GM growth 5Y1.45%
1MRKX.MI Yearly Profit, Operating, Gross Margins1MRKX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1MRKX is still creating some value.
Compared to 1 year ago, 1MRKX has about the same amount of shares outstanding.
1MRKX has less shares outstanding than it did 5 years ago.
1MRKX has a better debt/assets ratio than last year.
1MRKX.MI Yearly Shares Outstanding1MRKX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
1MRKX.MI Yearly Total Debt VS Total Assets1MRKX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

An Altman-Z score of 3.89 indicates that 1MRKX is not in any danger for bankruptcy at the moment.
1MRKX's Altman-Z score of 3.89 is in line compared to the rest of the industry. 1MRKX outperforms 55.56% of its industry peers.
The Debt to FCF ratio of 1MRKX is 3.17, which is a good value as it means it would take 1MRKX, 3.17 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1MRKX (3.17) is better than 62.96% of its industry peers.
1MRKX has a Debt/Equity ratio of 0.77. This is a neutral value indicating 1MRKX is somewhat dependend on debt financing.
1MRKX has a Debt to Equity ratio (0.77) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Altman-Z 3.89
ROIC/WACC1.57
WACC8.17%
1MRKX.MI Yearly LT Debt VS Equity VS FCF1MRKX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

1MRKX has a Current Ratio of 1.66. This is a normal value and indicates that 1MRKX is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.66, 1MRKX is doing good in the industry, outperforming 64.81% of the companies in the same industry.
A Quick Ratio of 1.44 indicates that 1MRKX should not have too much problems paying its short term obligations.
1MRKX has a Quick ratio of 1.44. This is in the better half of the industry: 1MRKX outperforms 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.44
1MRKX.MI Yearly Current Assets VS Current Liabilites1MRKX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

1MRKX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.07%, which is quite impressive.
Measured over the past years, 1MRKX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.04% on average per year.
1MRKX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.68%.
The Revenue has been growing by 10.40% on average over the past years. This is quite good.
EPS 1Y (TTM)48.07%
EPS 3Y6.87%
EPS 5Y8.04%
EPS Q2Q%70.7%
Revenue 1Y (TTM)1.68%
Revenue growth 3Y9.63%
Revenue growth 5Y10.4%
Sales Q2Q%3.72%

3.2 Future

1MRKX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.86% yearly.
1MRKX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.98% yearly.
EPS Next Y18.21%
EPS Next 2Y11.65%
EPS Next 3Y11.32%
EPS Next 5Y5.86%
Revenue Next Year1.08%
Revenue Next 2Y3.07%
Revenue Next 3Y3.96%
Revenue Next 5Y2.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1MRKX.MI Yearly Revenue VS Estimates1MRKX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
1MRKX.MI Yearly EPS VS Estimates1MRKX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.68 indicates a reasonable valuation of 1MRKX.
1MRKX's Price/Earnings ratio is rather cheap when compared to the industry. 1MRKX is cheaper than 85.19% of the companies in the same industry.
1MRKX is valuated cheaply when we compare the Price/Earnings ratio to 25.56, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.89, which indicates a very decent valuation of 1MRKX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1MRKX indicates a rather cheap valuation: 1MRKX is cheaper than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.62, 1MRKX is valued rather cheaply.
Industry RankSector Rank
PE 10.68
Fwd PE 9.89
1MRKX.MI Price Earnings VS Forward Price Earnings1MRKX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1MRKX is valued a bit cheaper than the industry average as 79.63% of the companies are valued more expensively.
66.67% of the companies in the same industry are more expensive than 1MRKX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.02
EV/EBITDA 8.9
1MRKX.MI Per share data1MRKX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

1MRKX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1MRKX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.59
PEG (5Y)1.33
EPS Next 2Y11.65%
EPS Next 3Y11.32%

5

5. Dividend

5.1 Amount

1MRKX has a Yearly Dividend Yield of 3.49%.
Compared to an average industry Dividend Yield of 3.01, 1MRKX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, 1MRKX pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.49%

5.2 History

The dividend of 1MRKX is nicely growing with an annual growth rate of 6.90%!
Dividend Growth(5Y)6.9%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1MRKX pays out 42.60% of its income as dividend. This is a bit on the high side, but may be sustainable.
1MRKX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP42.6%
EPS Next 2Y11.65%
EPS Next 3Y11.32%
1MRKX.MI Yearly Income VS Free CF VS Dividend1MRKX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1MRKX.MI Dividend Payout.1MRKX.MI Dividend Payout, showing the Payout Ratio.1MRKX.MI Dividend Payout.PayoutRetained Earnings

MERCK & CO. INC.

BIT:1MRKX (11/17/2025, 7:00:00 PM)

81.2

+0.1 (+0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners80.53%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap202.82B
Revenue(TTM)64.23B
Net Income(TTM)19.03B
Analysts75.76
Price Target87.23 (7.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.49%
Yearly Dividend2.66
Dividend Growth(5Y)6.9%
DP42.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.37%
Min EPS beat(2)7.69%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)7.28%
Min EPS beat(4)2.93%
Max EPS beat(4)13.06%
EPS beat(8)8
Avg EPS beat(8)21.72%
EPS beat(12)12
Avg EPS beat(12)16.45%
EPS beat(16)16
Avg EPS beat(16)15.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)0.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.41%
Revenue beat(12)9
Avg Revenue beat(12)1.14%
Revenue beat(16)13
Avg Revenue beat(16)1.98%
PT rev (1m)0.63%
PT rev (3m)0.11%
EPS NQ rev (1m)-6.85%
EPS NQ rev (3m)-7.2%
EPS NY rev (1m)0.24%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)-0.74%
Revenue NQ rev (3m)-0.76%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 10.68
Fwd PE 9.89
P/S 3.66
P/FCF 18.02
P/OCF 13.78
P/B 4.53
P/tB 15.73
EV/EBITDA 8.9
EPS(TTM)7.6
EY9.36%
EPS(NY)8.21
Fwd EY10.12%
FCF(TTM)4.51
FCFY5.55%
OCF(TTM)5.89
OCFY7.26%
SpS22.18
BVpS17.91
TBVpS5.16
PEG (NY)0.59
PEG (5Y)1.33
Graham Number55.33
Profitability
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROCE 24.24%
ROIC 12.83%
ROICexc 15.66%
ROICexgc 28.27%
OM 38.08%
PM (TTM) 29.63%
GM 78.72%
FCFM 20.31%
ROA(3y)9.42%
ROA(5y)9.66%
ROE(3y)23.17%
ROE(5y)26.32%
ROIC(3y)13.67%
ROIC(5y)12.02%
ROICexc(3y)15.77%
ROICexc(5y)13.76%
ROICexgc(3y)34.22%
ROICexgc(5y)31.54%
ROCE(3y)25.81%
ROCE(5y)22.7%
ROICexgc growth 3Y7.57%
ROICexgc growth 5Y3.37%
ROICexc growth 3Y15.27%
ROICexc growth 5Y10.69%
OM growth 3Y5.75%
OM growth 5Y7.99%
PM growth 3Y-0.15%
PM growth 5Y1.18%
GM growth 3Y1.92%
GM growth 5Y1.45%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Debt/EBITDA 1.38
Cap/Depr 87.9%
Cap/Sales 6.25%
Interest Coverage 18.43
Cash Conversion 58.79%
Profit Quality 68.56%
Current Ratio 1.66
Quick Ratio 1.44
Altman-Z 3.89
F-Score6
WACC8.17%
ROIC/WACC1.57
Cap/Depr(3y)95.66%
Cap/Depr(5y)110.48%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.78%
Profit Quality(3y)903.98%
Profit Quality(5y)573.68%
High Growth Momentum
Growth
EPS 1Y (TTM)48.07%
EPS 3Y6.87%
EPS 5Y8.04%
EPS Q2Q%70.7%
EPS Next Y18.21%
EPS Next 2Y11.65%
EPS Next 3Y11.32%
EPS Next 5Y5.86%
Revenue 1Y (TTM)1.68%
Revenue growth 3Y9.63%
Revenue growth 5Y10.4%
Sales Q2Q%3.72%
Revenue Next Year1.08%
Revenue Next 2Y3.07%
Revenue Next 3Y3.96%
Revenue Next 5Y2.98%
EBIT growth 1Y2.78%
EBIT growth 3Y15.93%
EBIT growth 5Y19.23%
EBIT Next Year29.99%
EBIT Next 3Y15.06%
EBIT Next 5Y10.12%
FCF growth 1Y-0.9%
FCF growth 3Y23.27%
FCF growth 5Y12.67%
OCF growth 1Y-0.73%
OCF growth 3Y15.02%
OCF growth 5Y9.82%

MERCK & CO. INC. / 1MRKX.MI FAQ

What is the ChartMill fundamental rating of MERCK & CO. INC. (1MRKX.MI) stock?

ChartMill assigns a fundamental rating of 7 / 10 to 1MRKX.MI.


What is the valuation status of MERCK & CO. INC. (1MRKX.MI) stock?

ChartMill assigns a valuation rating of 8 / 10 to MERCK & CO. INC. (1MRKX.MI). This can be considered as Undervalued.


What is the profitability of 1MRKX stock?

MERCK & CO. INC. (1MRKX.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for 1MRKX stock?

The Price/Earnings (PE) ratio for MERCK & CO. INC. (1MRKX.MI) is 10.68 and the Price/Book (PB) ratio is 4.53.


What is the financial health of MERCK & CO. INC. (1MRKX.MI) stock?

The financial health rating of MERCK & CO. INC. (1MRKX.MI) is 6 / 10.